Summary of Significant Accounting Policies - Additional Information (Details) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
$ / shares
|
Jun. 30, 2025
USD ($)
|
Jun. 30, 2026
USD ($)
Segment
$ / shares
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
$ / shares
|
|
| Product Information [Line Items] | |||||
| Impairment of long lived assets | $ 0 | $ 0 | $ 0 | $ 0 | |
| Number of reporting segments | Segment | 1 | ||||
| Percentage of valuation allowance on net deferred tax asset | 100.00% | 100.00% | |||
| Common stock par value | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||
| Deferred issuance cost | $ 0 | $ 0 | $ 150,000 | ||
| Credit losses | 0 | 0 | $ 0 | 0 | |
| AUSTRALIA | SAB BIO PTY LTD [Member] | |||||
| Product Information [Line Items] | |||||
| Effective income tax rate reconciliation tax credits research percentage | 48.50% | ||||
| Research and development tax credit | $ 200,000 | $ 300,000 | $ 300,000 | $ 800,000 | |
| Maximum [Member] | |||||
| Product Information [Line Items] | |||||
| Vesting period of awards | 10 years | ||||
| X | ||||||||||
- Definition Deferred Tax Assets, Valuation Allowance1 No definition available.
|
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation Tax Credits Research1 No definition available.
|
| X | ||||||||||
- Definition Short term and long term investments recognized credit losses. No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|